-
Notable Analyst rating Changes for 02/05: RMD, WFR, ALKS, SFN, BEBE Upgraded; FWD, EGOV, LEAP, COH, CIEN Downgraded
-
Notable Analyst Rating Changes 11/19: PSUN, LPX, SJM, SAFM Upgraded; SUN, SOL, GLW, CTRP Downgraded
-
BMO Downgrades ResMed (RMD) to Market Perform; $41 PT

